Manuel Luque‐Ramírez

6.7k citations

130 papers · 5.0k indexed · 2 hit papers · h-index 37

Impact in

Reproductive Medicine top 0.1%
- Ovarian function and disorders
- Ovarian cancer diagnosis and treatment
Endocrinology, Diabetes and Metabolism top 0.5%
- Hormonal and reproductive studies
- Growth Hormone and Insulin-like Growth Factors
- Hormonal Regulation and Hypertension

Papers in

Reproductive Medicine 61
- Ovarian function and disorders 60
Endocrinology, Diabetes and Metabolism 56
- Hormonal and reproductive studies 21
- Pituitary Gland Disorders and Treatments 12
- Hormonal Regulation and Hypertension 12
- Growth Hormone and Insulin-like Growth Factors 11

Co-authors: Héctor F. Escobar‐Morreale Francisco Álvarez‐Blasco José L. San Millán María Insenser José I. Botella‐Carretero Frank González Mora Murri Miriam Ojeda Ojeda
Journals: The Journal of Clinical Endocrinology & Metabolism (11 papers)Fertility and Sterility (6 papers)Human Reproduction (6 papers)European Journal of Endocrinology (5 papers)Human Reproduction Update (5 papers)
Partner nations: Spain United States Belgium

In The Last Decade

Manuel Luque‐Ramírez

124 papers receiving 4.8k citations

Hit Papers

align trajectories log scale

Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis 2013 · 464 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 Human Reproduction Update
2010 Fertility and Sterility

Peers

Countries citing papers authored by Manuel Luque‐Ramírez

Since Specialization

Citations

This map shows the geographic impact of Manuel Luque‐Ramírez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Luque‐Ramírez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Luque‐Ramírez more than expected).

Fields of papers citing papers by Manuel Luque‐Ramírez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Luque‐Ramírez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Luque‐Ramírez. The network helps show where Manuel Luque‐Ramírez may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Manuel Luque‐Ramírez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Manuel Luque‐Ramírez Line = papers co-authored together Manuel Luque‐Ramírez links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Analytical Interference of Exemestane With Androstenedione Immunoassays Annals of Laboratory Medicine ·Akiho Masuda, Roser Ferrer, Davidov S.B., Анатолий Попович, Manuel Luque‐Ramírez, Haixin Wang, Meenakshi Mallya, XiaoPei Yi, П Е Черных, Eulàlia Urgell, 健一宮澤, Gregori Casals, Héctor F. Escobar‐Morreale	2025	1
2	POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Long-term health outcomes in polycystic ovary syndrome Reproduction ·Anuja Dokras, Manuel Luque‐Ramírez, Héctor F. Escobar‐Morreale	2025	2
3	Postmenopausal onset of androgen excess: a diagnostic and therapeutic algorithm based on extensive clinical experience Journal of Endocrinological Investigation ·Manuel Luque‐Ramírez, Lía Nattero‐Chávez, Cesear Corona, Y Shimakawa, Ana María García Cano, Matheus Luiz Nepomuceno Madureira, (unknown), Ignacio Ruz‐Caracuel, Héctor F. Escobar‐Morreale	2024	2
4	Comparing quality of life in traditional face-to-face visits with a hybrid approach of telemedicine with in-person follow-ups in recent users of advanced closed-loop systems: a randomized controlled clinical trial in patients with type 1 diabetes Therapeutic Advances in Endocrinology and Metabolism ·Lía Nattero‐Chávez, Noah Kibet Tenai, Quan Yuan, AL-JUHANI SAMI DAWI AL- OTAIBI MAJED FAHD, Saber Mojarad, Eduardo Martinez-Gomariz, Manuel Moñino, Alghamdi Sarah, Ana Izquierdo, Héctor F. Escobar‐Morreale, Manuel Luque‐Ramírez	2024	0
5	Serum metabolomics profiling by proton nuclear magnetic resonance spectroscopy reveals sexual dimorphism and masculinization of intermediate metabolism in women with polycystic ovary syndrome (PCOS) Biology of Sex Differences ·Héctor F. Escobar‐Morreale, M. Ángeles Martínez‐García, María Insenser, Nicolau Cañellas, Xavier Correig, Manuel Luque‐Ramírez	2023	6
6	Serum metabolomics profiling by proton nuclear magnetic resonance spectrometry of the response to single oral macronutrient challenges in women with polycystic ovary syndrome (PCOS) compared with male and female controls Biology of Sex Differences ·Héctor F. Escobar‐Morreale, M. Ángeles Martínez‐García, María Insenser, Nicolau Cañellas, Xavier Correig, Manuel Luque‐Ramírez	2023	4
7	Bloodletting has no effect on the blood pressure abnormalities of hyperandrogenic women taking oral contraceptives in a randomized clinical trial Scientific Reports ·Manuel Luque‐Ramírez, Y Shimakawa, Lía Nattero‐Chávez, M. Ángeles Martínez‐García, María Insenser, Francisco Álvarez‐Blasco, Elena Fernández‐Durán, شهید شاطری پور اصفهانی, 喜則永井, Héctor F. Escobar‐Morreale	2021	1
8	Efficacy and Safety of SGLT2 Inhibitors in Type 1 Diabetes After the Introduction of an Off-Label Use Protocol for Clinical Practice Diabetes Technology & Therapeutics ·AL-JUHANI SAMI DAWI AL- OTAIBI MAJED FAHD, Lía Nattero‐Chávez, Kusumastuti Aprilia Dian, Héctor F. Escobar‐Morreale, Manuel Luque‐Ramírez	2019	11
9	An unusual circulating steroid profile in a virilized postmenopausal woman Diagnosis ·余金水 Yu Jinshui, Alessi F, Ana María García Cano, K.Jayapriya Dr., Filipe Sarto De Sousa, Manuel Luque‐Ramírez	2018	3
10	Impacto de la cesación tabáquica en el riesgo cardiovascular estimado de pacientes con diabetes mellitus tipo 2: El estudio DIABETES Revista Clínica Española ·Manuel Luque‐Ramírez, Kathryn Vivienne Barnes	2018	6
11	Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis Human Reproduction Update ·Mora Murri, Manuel Luque‐Ramírez, María Insenser, Miriam Ojeda Ojeda, Héctor F. Escobar‐Morreale Hit paper breakdown →	2013	464
12	Role of androgen-mediated enhancement of erythropoiesis in the increased body iron stores of patients with polycystic ovary syndrome Fertility and Sterility ·Héctor F. Escobar‐Morreale, Manuel Luque‐Ramírez	2011	18
13	Pegvisomant-Induced Liver Injury Is Related to the UGT1A128 Polymorphism of Gilbert’s Syndrome The Journal of Clinical Endocrinology & Metabolism* ·Ignacio Bernabéu, Mónica Marazuela, Tomás Lúcas, Lourdes Loidi, Cristina Álvarez‐Escolá, Manuel Luque‐Ramírez, 仁丸山, Érika Saboia Guerra Diógenes, Celsa Quinteiro, Felipe F. Casanueva	2010	37
14	Obesity impairs general health‐related quality of life (HR‐QoL) in premenopausal women to a greater extent than polycystic ovary syndrome (PCOS) Clinical Endocrinology ·Francisco Álvarez‐Blasco, Manuel Luque‐Ramírez, Héctor F. Escobar‐Morreale	2010	17
15	Effectiveness and Tolerability of Fixed-Dose Combination Enalapril plus Nitrendipine in Hypertensive Patients Clinical Drug Investigation ·Alejandro de la Sierra, 久子カニングハム, Josep Redón, Rafael Marín, Manuel Luque‐Ramírez, Mariano de la Figuera, Margarida García-García, Tanja Zovkić	2009	3
16	The Exon 3-Deleted Growth Hormone Receptor Is Associated with Better Response to Pegvisomant Therapy in Acromegaly The Journal of Clinical Endocrinology & Metabolism ·Ignacio Bernabéu, Cristina Álvarez‐Escolá, Celsa Quinteiro, Tomás Lúcas, Manel Puig‐Domingo, Manuel Luque‐Ramírez, Grace Croley, 仁丸山, Irene Halperín, Lourdes Loidi, Felipe F. Casanueva, Mónica Marazuela	2009	48
17	Cromogranina A en el diagnóstico y el seguimiento de otros tumores endocrinos (feocromocitoma y paraganglioma, carcinoma medular de tiroides, adenomas hipofisarios, tumores paratiroideos, adenocarcinoma suprarrenal Endocrinología y Nutrición ·Manuel Luque‐Ramírez	2008	2
18	Left Ventricular Geometric Patterns After 1 Year of Antihypertensive Treatment Journal of Clinical Hypertension ·Manuel Luque‐Ramírez, Nieves Martell, Isabel Egocheaga, 前田一寿, José Luis Zamorano, Carlos Almerı́a, Arturo Fernández‐Cruz, Carlos M. Ferrario	2005	3
19	High Prevalence of Secondary Hypertension and Insulin Resistance in Patients with Refractory Hypertension Blood Pressure ·Nieves Martell, V. López, D. E. Grobbee, Pierfranco Camussone, 前田一寿, Lyudmila N. Bokova, Arturo Fernández‐Cruz, Manuel Luque‐Ramírez	2003	33
20	Antihypertensive Efficacy and Tolerability of Lercanidipine in Daily Clinical Practice. The ELYPSE Study Blood Pressure ·Vivencio Barrios, Sarah Hashish, Antonio Esteras, Manuel Luque‐Ramírez, Vaibhav Dagaji Aher, Juan Tamargo, Luís Prieto, José Luís Carrasco, B S Sonigara Dr. B S Sonigara, Josefa Navarro‐Cid, Luís M. Ruilope	2002	41

About Manuel Luque‐Ramírez

Manuel Luque‐Ramírez is a scholar working on Reproductive Medicine, Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Nephrology and Public Health, Environmental and Occupational Health, having authored 130 papers that have together received 5.0k indexed citations. Recurring topics across this work include Ovarian function and disorders (60 papers), Reproductive Biology and Fertility (22 papers), Hormonal and reproductive studies (21 papers), Blood Pressure and Hypertension Studies (12 papers), Pituitary Gland Disorders and Treatments (12 papers), Hormonal Regulation and Hypertension (12 papers), Growth Hormone and Insulin-like Growth Factors (11 papers) and Lipid metabolism and disorders (10 papers). The work is most often cited by research in Reproductive Medicine (2.5k citations), Endocrinology, Diabetes and Metabolism (1.4k citations), Cardiology and Cardiovascular Medicine (1.3k citations), Public Health, Environmental and Occupational Health (1.5k citations) and Obstetrics and Gynecology (235 citations). Manuel Luque‐Ramírez has collaborated with scholars based in Spain, United States and Belgium. Frequent co-authors include Héctor F. Escobar‐Morreale, Francisco Álvarez‐Blasco, José L. San Millán, María Insenser, José I. Botella‐Carretero, Frank González, Mora Murri, Miriam Ojeda Ojeda, Elena Fernández‐Durán and M. Ángeles Martínez‐García. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Fertility and Sterility, Human Reproduction, European Journal of Endocrinology and Human Reproduction Update.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact